TCIIS
EW icon

TIAA-CREF Individual & Institutional Services’s Edwards Lifesciences EW Stock Holding History

TIAA-CREF Individual & Institutional Services’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$823K Sell
9,102
-736
-7% -$61.7K ﹤0.01% 379
2026
Q1 		$788K Buy
+9,838
New +$811K ﹤0.01% 370

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

TIAA-CREF Individual & Institutional Services's EW Position: Q2 2026 in Review

TIAA-CREF Individual & Institutional Services reduced its Edwards Lifesciences (EW) stake by 7.5% in Q2 2026, selling an estimated $61.7K and leaving 9,102 shares worth $823K. The position accounts for ﹤0.01% of the portfolio, ranked #379.

TIAA-CREF Individual & Institutional Services first reported a position in EW in Q1 2026 and has held it in 2 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • TIAA-CREF Individual & Institutional Services held 9,102 shares of Edwards Lifesciences worth $823K as of Q2 2026.
  • TIAA-CREF Individual & Institutional Services sold 736 Edwards Lifesciences shares in Q2 2026, an estimated $61.7K.
  • Edwards Lifesciences made up ﹤0.01% of TIAA-CREF Individual & Institutional Services's portfolio in Q2 2026, its #379 holding.
  • TIAA-CREF Individual & Institutional Services first reported a position in Edwards Lifesciences in Q1 2026 and has held it in 2 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on TIAA-CREF Individual & Institutional Services's 13F filing for Q2 2026, filed 10 Aug 2026.